Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. SGRY
SGRY logo

SGRY Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
13.570
Open
13.010
VWAP
13.30
Vol
4.33M
Mkt Cap
1.68B
Low
12.850
Amount
57.60M
EV/EBITDA(TTM)
10.26
Total Shares
129.42M
EV
6.95B
EV/OCF(TTM)
25.35
P/S(TTM)
0.50
Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility Services segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of 162 surgical facilities comprised of 143 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 250 locations in 30 states, including short-stay surgical hospitals.
Show More

Events Timeline

(ET)
2026-03-03
09:00:00
U.S. Stock Futures Sharply Lower as Oil Prices Surge Raises Concerns
select
2026-03-02 (ET)
2026-03-02
19:40:00
Middle East Turmoil Causes WTI Crude Oil to Surge Nearly 10%
select

News

Newsfilter
9.5
13:41 PMNewsfilter
PinnedSurgery Partners Reports 4.2% Decline in Q4 Adjusted EBITDA
  • Financial Performance Gap: Surgery Partners reported an Adjusted EBITDA of $136.4 million for Q4 2025, reflecting a 4.2% decline compared to the previous year, creating a stark contrast with management's earlier profit expectations and undermining investor confidence.
  • Negative Market Reaction: Despite management's claims of a 6.1% growth in Adjusted EBITDA for Q3 and a 16.6% margin, the decline in Q4 led to a sharp drop in SGRY shares, indicating market concerns over the company's future profitability.
  • Legal Investigation Initiated: Following discrepancies in financial reporting, Levi & Korsinsky LLP is investigating potential securities law violations by Surgery Partners, encouraging affected shareholders to provide information for legal recourse.
  • Uncertain Outlook: Management's previous optimism regarding future margin expansion is now clouded by the recent performance decline, raising doubts among investors about the company's growth prospects and potentially impacting its long-term investment appeal.
seekingalpha
4.5
03-10seekingalpha
Activist Investor Calls for Surgery Partners to Sell Hospitals
  • Asset Sale Proposal: Activist investor Ortelius Advisors is urging Surgery Partners to divest all of its surgical hospitals, which is expected to generate billions in asset sales, thereby providing the capital necessary for stock buybacks, debt reduction, and improved creditworthiness.
  • Management Overhaul: Ortelius is also calling for a refresh of Surgery Partners' board and the installation of a new management team, aiming to enhance corporate governance and strengthen market competitiveness through a strategic review.
  • Financial Outlook Improvement: Ortelius highlighted that after the sale of hospitals, the remaining entity would focus on ambulatory surgery centers, which are projected to exhibit stronger revenue growth, higher EBITDA margins, and larger free cash flow yields, thus warranting an expanded enterprise value to EBITDA multiple.
  • Market Reaction: Although Surgery Partners has not yet responded to these proposals, the company is set to present at the Barclays 28th Annual Global Healthcare Conference, which may draw investor attention to its future strategic direction.
Newsfilter
6.5
03-10Newsfilter
Surgery Partners Faces Value Destruction and Accountability Demands
  • Shareholder Value Loss: Over the past five years, Surgery Partners' stock price has plummeted by 67%, lagging benchmarks by 108 percentage points, indicating severe underperformance and a significant decline in shareholder confidence.
  • Peer Comparison Deficit: Compared to HCA Healthcare and Tenet Healthcare, Surgery Partners has underperformed by 276 and 413 percentage points in total shareholder returns, highlighting a critical need for strategic measures to regain competitive standing in the industry.
  • Asset Divestiture Potential: Ortelius suggests that divesting all surgical hospitals could generate billions in asset sales, providing the necessary capital for stock repurchases and debt reduction, thereby improving the company's financial health and creditworthiness.
  • Need for Management Change: Ortelius calls for substantial changes in the board and management team to address serious governance and execution failures, aiming to restore shareholder trust in the company's leadership.
Newsfilter
1.0
03-09Newsfilter
Surgery Partners to Present at Barclays Healthcare Conference
  • Investor Meeting Schedule: Surgery Partners is set to present at the Barclays 28th Annual Global Healthcare Conference on March 10, 2026, at 2:30 p.m. Eastern Time, which is expected to attract significant investor interest.
  • Webcast Availability: The event will be available via a simultaneous webcast through the company's investor relations section, allowing investors to access the replay for a limited time post-event, ensuring broad dissemination and transparency of information.
  • Company Background: Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners is one of the largest surgical services companies in the U.S., operating over 200 locations across 30 states, focusing on high-quality, cost-effective surgical and ancillary care solutions.
  • Business Model Advantage: The company employs a differentiated outpatient delivery model aimed at meeting the needs of both patients and physicians, significantly enhancing its market position and growth potential amid rising demand for healthcare services.
moomoo
6.0
03-05moomoo
SURGERY PARTNERS INC: UBS LOWERS TARGET PRICE FROM $29 TO $21
  • Surgery Partners Inc. Update: The company has announced a significant reduction in its target price.

  • New Target Price: The target price has been lowered from $29 to $21.

NASDAQ.COM
8.0
03-04NASDAQ.COM
Royal Caribbean Group Sees Surge in Options Trading Volume
  • Surge in Options Volume: Royal Caribbean Group (RCL) recorded an options trading volume of 31,614 contracts today, equivalent to approximately 3.2 million shares, which is 134.7% of its average daily trading volume over the past month, indicating strong market interest in the stock.
  • High Demand Options: Notably, the $350 strike call option expiring on April 17, 2026, saw 8,036 contracts traded today, representing about 803,600 underlying shares of RCL, suggesting investor expectations for future price increases.
  • Surgery Partners Options Activity: Concurrently, Surgery Partners Inc (SGRY) experienced an options trading volume of 20,059 contracts today, equivalent to approximately 2.0 million shares, which is 97.5% of its average daily trading volume over the past month, highlighting the stock's market activity.
  • Put Option Demand: Specifically, the $15 strike put option expiring on June 18, 2026, recorded a trading volume of 10,000 contracts today, representing around 1.0 million underlying shares of SGRY, reflecting investor concerns about potential declines in the stock's future performance.
Wall Street analysts forecast SGRY stock price to rise
11 Analyst Rating
Wall Street analysts forecast SGRY stock price to rise
8 Buy
3 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
18.00
Averages
26.30
High
36.00
Current: 0.000
sliders
Low
18.00
Averages
26.30
High
36.00
UBS
Buy
downgrade
$29 -> $21
AI Analysis
2026-03-05
Reason
UBS
Price Target
$29 -> $21
AI Analysis
2026-03-05
downgrade
Buy
Reason
UBS lowered the firm's price target on Surgery Partners to $21 from $29 and keeps a Buy rating on the shares. The company attributed the Q4 EBITDA miss to underperformance at three specific surgical hospital markets, the analyst tells investors in a research note.
Mizuho
Ann Hynes
Outperform
downgrade
$19 -> $17
2026-03-05
Reason
Mizuho
Ann Hynes
Price Target
$19 -> $17
2026-03-05
downgrade
Outperform
Reason
Mizuho analyst Ann Hynes lowered the firm's price target on Surgery Partners to $17 from $19 and keeps an Outperform rating on the shares. The company reported lower than expected Q4 results, driven by anesthesia-related cost pressures and a deteriorating payer mix due to a higher Medicare mix, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SGRY
Unlock Now

Valuation Metrics

The current forward P/E ratio for Surgery Partners Inc (SGRY.O) is 24.62, compared to its 5-year average forward P/E of -331.85. For a more detailed relative valuation and DCF analysis to assess Surgery Partners Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-331.85
Current PE
24.62
Overvalued PE
1312.09
Undervalued PE
-1975.80

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
17.96
Current EV/EBITDA
13.01
Overvalued EV/EBITDA
21.62
Undervalued EV/EBITDA
14.29

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.26
Current PS
0.56
Overvalued PS
1.65
Undervalued PS
0.86

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

market movers ready to brakeout
Intellectia · 14 candidates
Rsi Category: moderateRelative Vol: >= 1.80Week Price Change Pct: $3.00 - $15.00Support Resistance Relationship: PriceAroundResistance, PriceAroundUpperBollMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
NTLA logo
NTLA
Intellia Therapeutics Inc
1.82B
POET logo
POET
POET Technologies Inc
1.06B
NTR logo
NTR
Nutrien Ltd
36.44B
AMBP logo
AMBP
Ardagh Metal Packaging SA
2.90B
SGRY logo
SGRY
Surgery Partners Inc
2.05B
ALMU logo
ALMU
Aeluma Inc
347.27M
create a small cap screener
Intellectia · 1387 candidates
Market Cap Category: small
Ticker
Name
Market Cap$
top bottom
SGRY logo
SGRY
Surgery Partners Inc
2.00B
QDEL logo
QDEL
QuidelOrtho Corp
2.00B
NESR logo
NESR
National Energy Services Reunited Corp
2.00B
DXPE logo
DXPE
DXP Enterprises Inc
2.00B
SKWD logo
SKWD
Skyward Specialty Insurance Group Inc
2.00B
NTCT logo
NTCT
Netscout Systems Inc
2.00B
small cap stocks $20 and under
Intellectia · 870 candidates
Price: <= $20.00Market Cap Category: small
Ticker
Name
Market Cap$
top bottom
NESR logo
NESR
National Energy Services Reunited Corp
2.00B
SGRY logo
SGRY
Surgery Partners Inc
2.00B
FMC logo
FMC
FMC Corp
1.99B
HLMN logo
HLMN
Hillman Solutions Corp
1.96B
SBET logo
SBET
SharpLink Gaming Inc
1.96B
RNW logo
RNW
Renew Energy Global PLC
1.95B

Whales Holding SGRY

D
Davidson Kempner Capital Management LP
Holding
SGRY
+12.30%
3M Return
G
Glenview Capital Management, LLC
Holding
SGRY
-4.63%
3M Return
P
Pentwater Capital Management LP
Holding
SGRY
-5.54%
3M Return
J
Jaunty Global Limited
Holding
SGRY
-9.62%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Surgery Partners Inc (SGRY) stock price today?

The current price of SGRY is 13.48 USD — it has increased 4.09

What is Surgery Partners Inc (SGRY)'s business?

Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility Services segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of 162 surgical facilities comprised of 143 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 250 locations in 30 states, including short-stay surgical hospitals.

What is the price predicton of SGRY Stock?

Wall Street analysts forecast SGRY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SGRY is26.30 USD with a low forecast of 18.00 USD and a high forecast of 36.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Surgery Partners Inc (SGRY)'s revenue for the last quarter?

Surgery Partners Inc revenue for the last quarter amounts to 885.00M USD, increased 2.38

What is Surgery Partners Inc (SGRY)'s earnings per share (EPS) for the last quarter?

Surgery Partners Inc. EPS for the last quarter amounts to -0.12 USD, decreased -86.05

How many employees does Surgery Partners Inc (SGRY). have?

Surgery Partners Inc (SGRY) has 16000 emplpoyees as of March 11 2026.

What is Surgery Partners Inc (SGRY) market cap?

Today SGRY has the market capitalization of 1.68B USD.